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Platelet activating factor (PAP’) is a proinflam- 
matory mediator released during ntyocardial isch- 
emia. To determine if PAF is important in reper- 
fusion (RP) in jury, closed chest dogs underwent 
90 min occlusion of the LAD (angioplasty balloon) 
and 3 days of RP. The PAF antagonist EN50739 (5 
mg/kg iv: n=lO) was given 15 min before RP and 
912 hrs x 24 hrs post+@: controls (n=8) received 
vehicle. Anterolateral ejection fraction (EF) 
was a~sssssd by contrast v ntriculography before 
LhD occlusion (baseline) and after 3 days of RP. 
The area at risk (AR) was defined by injection of 
uonastral blue dye during a repeat LAD elusion 
on day 3. The area of necrosis (NJ) wa easured 
from LV slices unstained by TTC. PAF ibition 
was sustained for 36 hrs post-RP (by ex vivo PAF- 
induced platelet aggregation). BN50739 produced 
no adverse effects: collateral blood flow (micro- 
infarct size but does not significantly 
regional LV function 3 days post-RP. 
improve 
2) These 
data suggest that PAF is an important mediator in 
thepathogenesisofmyocardialreperfusioninjury. 
perfused in an isovolumic 
Krebs-Henseleit solution 
flow” followed by 30 
reperfuslon, CPK release 
mlnutes of reperfusion: 
786i66 mm Hglsec, vehklem523k102 
developed pressure (30 minutes of 
42.3&3 mm Hg, vehlcle=26.5&6 
demonstrated in the U74006F group. 
treatment wlth U74008F results tn less myocardial necrosis and 
Improved early recovery of myocardial function. This may occur 
through protection against lipid peroxidatkn. 
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Ieukotrienas W,E4 ElW are potent Comarary vasoccn- 
stricters. This study investigated the role of cardiac 
synlAesized Ws in rclyocardial reperfusion injury. Xn- 
creased cardiac mthesis of LTS was first mtrated 
in isolated, crystalloid-perfused rat hearts subjected to 
2hrs glcbal is&da at 1% W3). postiscihgnic LT pro- 
duction was elevatzd QQnpBLBd to preisdranic values (170 
vs ll7pg/.lrfU. LC content wee analysed by radioimmune 
assay. Nact,the effects of LT inhibitian an aoranary flaw 
and ventricular function using a L!tW,E4 recepbx antago- 
nist,LY171883,were assessed. titer baseline measurarrents, 
heartswerearrestedwithstanbd 
03 w-6) or c plus Ly1718a3 (xl0 $0 
stassiun cardiuplegia 
M) (D) N6) for 2hrs 
hypotkxb glcbal iscbnia,folluwed +y 3Qnin reperfusion. 
FWxentreaweryof alrcmry flow(c!F) ,caxdiac output (00) 
heart rate(HR) ,stm?te work(SW) and 
sistancsEVRl were debxmined 
comnaryvascular~ 
frpn baseline and post- 
7 fF P P % cvp 53.3-6.2 49.7-4.9 93.5-10.2 53.7 .3 181.1~28.4 
D 81.7t6.9 78.6e.4 96.0+6.4 82.3110.7 121.2fl3.4 
PWllue 0.0001 0.0001 NS 0.0002 0.0009 
IheSe results dE!nmstate that (1) Us are endogencxsly pro- 
duced, with increased probctim after i-a and(2)in- 
hibitdn with a receptor anbqonist improves coronary flow 
andfunctional reowery. Cardiac derived ISs partly fxm- 
trolooraLaryflawandincreasedp~ctionnreybeanin- 
tssral f2cWment of xryoadial reperfusion injury. 
PROGNOSIS OF PATIENTS WITHOUT MYOCARDIAL NECROSIS 
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The outcome of r&PA therapy in patients with prolonged 
rest angina who present with ST segment elevation has not 
been well studied. The TIiW II trial assigned 3,339 
patients (pts) with suspected acute myocardial infarction 
(MI) within 4 hours of symptom onset to an invasive or 
conservative strategy. In this report, we compared the 3- 
week and l-year incidence of death and new MI in 102 pts 
presenting with chest pain 2 30 min., ST segment 
elevation, absence of serial Q wave changes, and serial CK 
values c 2 x upper limit of normal (group 1) to 3,237 pts 
witb confirmed MI (group 2). All pts were treated with rt- 
PA, heparin, and aspirin. Death and MI rates were 
Group 2 (n=3,237) 4.7 7.3 6.3 9.6 
randomized to the conservative strategy was similar-in 
both groups (p=O.12). Thus, pts with prolonged chest pain 
and ST segment elevation who do not develop myocardial 
necrosis have a low l-year mortality, less than pts with 
confirmed MI (p=O.O2). There remains a high incidence of 
subsequent myocardial infarction in both group 1 and 2 pts 
treated with rt-PA, heparin, and aspirin. 
